Many people infected with SARS-CoV-2 do not develop antibodies to the virus.
“The authors of the study tested the participants' blood for the presence of antibodies to the spike protein (the primary infectious particle of the SARS-CoV-2 virus) as well as other viral particles at the time of enrollment and at subsequent follow-up visits.”